Shanghai, China

Hongyu Yang

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Xdcexplorer (Shanghai) Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongyu Yang. Retrieved from https://idiyas.com/inventor/hongyu-yang-ekqmjf0w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hongyu Yang

Introduction

Hongyu Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antibody drug conjugates. His innovative work has led to advancements that improve drug efficacy and safety.

Latest Patents

Hongyu Yang holds a patent for an antibody drug conjugate, which includes an intermediate, preparation method, pharmaceutical composition, and various uses. The patent describes an antibody drug conjugate that utilizes ether linkages for connection, enhancing water solubility, stability, and cytotoxicity both in vivo and in vitro. The synthetic process is characterized by simple steps and high yield, making it a valuable contribution to the pharmaceutical industry. He has 1 patent to his name.

Career Highlights

Yang is currently employed at Xdcexplorer (Shanghai) Co., Ltd., where he continues to push the boundaries of innovation in drug development. His work is instrumental in creating more effective therapeutic options for patients.

Collaborations

He collaborates with notable colleagues, including Jason Shaoyun Xiang and Shifeng Liu, who contribute to his research and development efforts.

Conclusion

Hongyu Yang's contributions to the field of pharmaceutical sciences exemplify the impact of innovative thinking in drug development. His work on antibody drug conjugates is paving the way for future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…